Literature DB >> 406783

Evidence for preferential X-chromosome inactivation in a family with Fabry disease.

H H Ropers, T F Wienker, T Grimm, K Schroetter, K Bender.   

Abstract

Severe clinical signs of Fabry disease were observed in four of eight heterozygous daughters of a male patient. Activities of alpha-galactosidase A in serum, white blood cells, and hair roots of the manifesting carriers were markedly lower than 50% of normal. These findings are not easy to interpret in terms of random X inactivation alone; several alternative models including nonrandom (preferential) X inactivation are discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 406783      PMCID: PMC1685395     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  12 in total

Review 1.  The applications of genetic mosaicism to developmental problems.

Authors:  M N Nesbitt; S M Gartler
Journal:  Annu Rev Genet       Date:  1971       Impact factor: 16.830

2.  Genetic determination of the alpha-galactosidase developmental program in mice.

Authors:  A J Lusis; K Paigen
Journal:  Cell       Date:  1975-11       Impact factor: 41.582

3.  Lesch-Nyhan syndrome: absence of the mutant enzyme in erythrocytes of a heterozygote for both normal and mutant hypoxanthine-guanine phosphoribosyl transferase.

Authors:  J A McDonald; W N Kelley
Journal:  Biochem Genet       Date:  1972-02       Impact factor: 1.890

4.  Mosaicism of peripheral blood lymphocyte populations in females heterozygous for the Lesch-Nyhan mutation.

Authors:  R J Albertini; R DeMars
Journal:  Biochem Genet       Date:  1974-05       Impact factor: 1.890

5.  The manifesting carrier in Duchenne muscular dystrophy.

Authors:  H Moser; A E Emery
Journal:  Clin Genet       Date:  1974       Impact factor: 4.438

6.  X chromosome inactivation mosaicism in the mouse.

Authors:  M N Nesbit
Journal:  Dev Biol       Date:  1971-10       Impact factor: 3.582

7.  Linkage relationships of the angiokeratoma (Fabry) locus.

Authors:  A W Johnston; P Frost; G L Spaeth; J H Renwick
Journal:  Ann Hum Genet       Date:  1969-05       Impact factor: 1.670

8.  Residual activity of alpha-galactosidase A in Fabry's disease.

Authors:  G Romeo; M D'Urso; A Pisacane; E Blum; A De Falco; A Ruffilli
Journal:  Biochem Genet       Date:  1975-10       Impact factor: 1.890

9.  Complementation after fusion of Sandhoff- and Tay-Sachs fibroblasts.

Authors:  H H Ropers; K H Grzeschik; E Bühler
Journal:  Humangenetik       Date:  1975

10.  The Genetics of Angiokeratoma Corporis Diffusum (Fabry's Disease) and Its Linkage Relations with the Xg Locus.

Authors:  J M Opitz; F C Stiles; D Wise; R R Race; R Sanger; G R Von Gemmingen; R R Kierland; E G Cross; W P De Groot
Journal:  Am J Hum Genet       Date:  1965-07       Impact factor: 11.025

View more
  9 in total

1.  Progressive myoclonus epilepsy. A variant with probable X-linked inheritance.

Authors:  T F Wienker; G M von Reutern; H H Ropers
Journal:  Hum Genet       Date:  1979-05-23       Impact factor: 4.132

2.  Anderson-Fabry disease in Austria.

Authors:  Matthias Lorenz; Anna-Christina Hauser; Margot Püspök-Schwarz; Peter Kotanko; Ingrid Arias; Herbert Zodl; Reinhard Kramar; Eduard Paschke; Till Voigtländer; Gere Sunder-Plassmann
Journal:  Wien Klin Wochenschr       Date:  2003-04-30       Impact factor: 1.704

Review 3.  [Females with Fabry's disease - an interdisciplinary diagnostic and therapeutic challenge].

Authors:  Frank Weidemann; Markus Niemann; Claudia Sommer; Meinrad Beer; Frank Breunig; Christoph Wanner
Journal:  Med Klin (Munich)       Date:  2010-09-28

4.  X chromosome-linked and mitochondrial gene control of Leber hereditary optic neuropathy: evidence from segregation analysis for dependence on X chromosome inactivation.

Authors:  X D Bu; J I Rotter
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

5.  Different phenotypic expression of Fabry disease in female monozygotic twins.

Authors:  T Levade; F Giordano; A Maret; M C Marguery; J Bazex; R Salvayre
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

Review 6.  Genetic control of X inactivation and processes leading to X-inactivation skewing.

Authors:  J W Belmont
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

7.  A Fabry's disease heterozygote with a new mutation: biochemical, ultrastructural, and clinical investigations.

Authors:  L Hasholt; S A Sørensen; A Wandall; E B Andersen; P Arlien-Søborg
Journal:  J Med Genet       Date:  1990-05       Impact factor: 6.318

8.  A skewed view of X chromosome inactivation.

Authors:  Jakub Minks; Wendy P Robinson; Carolyn J Brown
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

9.  X-chromosome methylation in manifesting and healthy carriers of dystrophinopathies: concordance of activation ratios among first degree female relatives and skewed inactivation as cause of the affected phenotypes.

Authors:  J Azofeifa; T Voit; C Hübner; M Cremer
Journal:  Hum Genet       Date:  1995-08       Impact factor: 4.132

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.